First To Know

The First To Know® Syphilis Test is the first and only Over-the-Counter test for the detection of antibodies to the bacteria that cause syphilis. It provides an accurate, in-home result in 15 minutes with a single drop of blood and is easy to use, empowering everyone to take control of their health and be the first to know. The test received marketing authorization from the FDA through the de novo pathway, recognizing it as a novel device for syphilis testing in the United States, distinguishing it from other products on the market. Syphilis infections have surged to epidemic levels, heights not seen since the 1950s. This alarming trend underscores the critical need for accessible and reliable testing solutions. Syphilis can lead to serious health complications if left untreated. One of the challenges in combating syphilis is that it often does not present noticeable symptoms, making regular testing crucial for those at risk. The First To Know® Syphilis Test addresses this urgent public health need by enabling access to convenient, private and accurate testing with results in minutes. *Learn more at www.firsttoknow.com.

• Employees 0
• Founded 2024
• Annual Revenue $10000000